IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer.
Xiao-Hui LiGui-Zhong HuangZi-Lan XuChong-Yu ZhaoXiao-Yuan DongBo-Kang CuiXiao-Jun LinPublished in: Journal of translational medicine (2023)
Our findings demonstrate that IL20RB plays a crucial role in promoting stemness in pancreatic cancer. This discovery provides a potential therapeutic target for this lethal disease.